Precision BioSciences Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Precision BioSciences, Inc. on November 8, 2019. The company is incorporated in Delaware and its common stock trades on the Nasdaq Global Select Market under the symbol "DTIL". The filing serves as a disclosure of investor presentation materials.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing regarding the distribution of presentation materials rather than a financial statement.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing solely announces the company's participation in meetings with investors and analysts.
Guidance, Outlook, and Risks
The company disclosed that it will be participating in meetings with investors and analysts. Presentation materials used for these meetings are furnished as Exhibit 99.1 and are available on the company's Investor Relations website. The filing explicitly states that the information in Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference into other filings except as expressly set forth.
Key Facts for Investor Verification
- Verify the content of the investor presentation materials (Exhibit 99.1) available on the company's website for specific business updates.
- Note that the presentation materials are not legally "filed" with the SEC and carry different liability standards than formal financial reports.
- Confirm the company's status as an emerging growth company, which may affect financial reporting requirements.